Identification of MAGEA Antigens as Causal Players in the Development of Tamoxifen-Resistant Breast Cancer

Oncogene - United Kingdom
doi 10.1038/onc.2014.45
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Development of New Estrogen Receptor-Targeting Therapeutic Agents for Tamoxifen-Resistant Breast Cancer

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2013English

Inhibiting PAD2 Enhances the Anti-Tumor Effect of Docetaxel in Tamoxifen-Resistant Breast Cancer Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Expression of Cyclin D1 in Tamoxifen Resistant Subline of Human Breast Cancer T47D Cells

International Journal of Cancer Research
Cancer ResearchOncology
2005English

Cyclophosphamide and Tamoxifen as Adjuvant Therapies in the Management of Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
1988English

High-Density Array Analysis of DNA Methylation in Tamoxifen-Resistant Breast Cancer Cell Lines

Epigenetics
Cancer ResearchMedicineMolecular Biology
2013English

Hedgehog Acyltransferase as a Target in Estrogen Receptor Positive, HER2 Amplified, and Tamoxifen Resistant Breast Cancer Cells

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2015English

TP53 Upregulates Α‑smooth Muscle Actin Expression in Tamoxifen‑resistant Breast Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2018English

Heregulin Β1 Drives Gefitinib-Resistant Growth and Invasion in Tamoxifen-Resistant McF-7 Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2007English

Use of Next Generation Sequencing in the Identification of Long Non-Coding RNAs as Potential Players in Breast Cancer Prevention

Transcriptomics: Open Access
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy